Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherRevenue (Gross)
Ratios

Abeona Therapeutics (ABEO) Leases (2019 - 2025)

Abeona Therapeutics has reported Leases over the past 7 years, most recently at $4.0 million for Q4 2025.

  • Quarterly results put Leases at $4.0 million for Q4 2025, up 11.54% from a year ago — trailing twelve months through Dec 2025 was $4.0 million (up 11.54% YoY), and the annual figure for FY2025 was $4.0 million, up 11.54%.
  • Leases for Q4 2025 was $4.0 million at Abeona Therapeutics, down from $4.1 million in the prior quarter.
  • Over the last five years, Leases for ABEO hit a ceiling of $9.4 million in Q4 2021 and a floor of $3.6 million in Q4 2024.
  • Median Leases over the past 5 years was $4.8 million (2023), compared with a mean of $5.3 million.
  • Biggest five-year swings in Leases: surged 33.72% in 2021 and later crashed 43.31% in 2022.
  • Abeona Therapeutics' Leases stood at $9.4 million in 2021, then crashed by 43.31% to $5.3 million in 2022, then fell by 16.43% to $4.5 million in 2023, then dropped by 20.27% to $3.6 million in 2024, then grew by 11.54% to $4.0 million in 2025.
  • The last three reported values for Leases were $4.0 million (Q4 2025), $4.1 million (Q3 2025), and $4.1 million (Q2 2025) per Business Quant data.